Insider: ROTHBLATT MARTINE A Chairperson & CEO - UNITED THERAPEUTICS CORP
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 46,193 | 545,634 | 591,827 |
| Value | $26,090,268.33 | $308,179,567.78 | $334,269,836.11 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/01/2026 | DDS | 360 | Direct | COM | $577.13 | $207,767.92 | 46,193 |
| 04/01/2026 | DDS | 399 | Direct | COM | $576.02 | $229,831.46 | 46,553 |
| 04/01/2026 | DDS | 240 | Direct | COM | $578.56 | $138,855.43 | 45,953 |
| 04/01/2026 | DDS | 190 | Direct | COM | $580.54 | $110,302.87 | 45,483 |
| 04/01/2026 | DDS | 610 | Direct | COM | $581.72 | $354,847.55 | 44,873 |
| 04/01/2026 | DDS | 481 | Direct | COM | $574.87 | $276,511.56 | 46,952 |
| 04/01/2026 | DDS | 310 | Direct | COM | $573.92 | $177,916.16 | 47,433 |
| 04/01/2026 | DDS | 240 | Direct | COM | $596.11 | $143,065.99 | 40,513 |
| 04/01/2026 | DDS | 538 | Direct | COM | $570.87 | $307,126.34 | 49,475 |
| 04/01/2026 | DDS | 801 | Direct | COM | $571.58 | $457,836.54 | 48,674 |
| 04/01/2026 | DDS | 931 | Direct | COM | $572.81 | $533,283.50 | 47,743 |
| 04/01/2026 | DDS | 602 | Direct | COM | $582.75 | $350,816.70 | 44,271 |
| 04/01/2026 | DDS | 280 | Direct | COM | $579.35 | $162,217.47 | 45,673 |
| 04/01/2026 | DDS | 31 | Direct | COM | $583.56 | $18,090.36 | 44,240 |
| 04/01/2026 | DDS | 155 | Direct | COM | $590.69 | $91,556.45 | 41,913 |
| 04/01/2026 | DDS | 240 | Direct | COM | $592.98 | $142,316.38 | 41,393 |
| 04/01/2026 | DDS | 440 | Direct | COM | $594.11 | $261,408.62 | 40,953 |
| 04/01/2026 | DDS | 200 | Direct | COM | $595.29 | $119,058.40 | 40,753 |
| 04/01/2026 | DDS | 469 | Direct | COM | $589.66 | $276,551.24 | 42,068 |
| 04/01/2026 | DDS | 280 | Direct | COM | $591.64 | $165,659.17 | 41,633 |
| 04/01/2026 | DDS | 160 | Direct | COM | $585.11 | $93,617.73 | 44,080 |
| 04/01/2026 | DDS | 450 | Direct | COM | $588.63 | $264,882.92 | 42,537 |
| 04/01/2026 | DDS | 247 | Direct | COM | $586.61 | $144,893.61 | 43,833 |
| 04/01/2026 | DDS | 846 | Direct | COM | $587.60 | $497,111.55 | 42,987 |
| 03/31/2026 | DDS | 805 | Direct | COM | $582.19 | $468,665.85 | 48,225 |
| 1 2 3 4 5 6 7 8 9 10 Next Last You are at page 1 of 149 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research